======= LMO3 ======= == Gene Information == * **Official Symbol**: LMO3 * **Official Name**: LIM domain only 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55885|55885]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TAP4|Q8TAP4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LMO3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LMO3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/180386|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the rhombotin family of cysteine-rich LIM domain oncogenes. This gene is predominantly expressed in the brain. Related family members, LMO1 and LMO2 on chromosome 11, have been reported to be involved in chromosomal translocations in T-cell leukemia. Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]. * **UniProt Summary**: N/A |LIM| |positive regulation of glucocorticoid receptor signaling pathway| |regulation of glucocorticoid receptor signaling pathway| |positive regulation of peroxisome proliferator activated receptor signaling pathway| |positive regulation of intracellular steroid hormone receptor signaling pathway| |regulation of peroxisome proliferator activated receptor signaling pathway| |positive regulation of fat cell differentiation| |negative regulation of ERK1 and ERK2 cascade| |regulation of intracellular steroid hormone receptor signaling pathway| |regulation of fat cell differentiation| |negative regulation of MAPK cascade| |regulation of ERK1 and ERK2 cascade| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |negative regulation of intracellular signal transduction| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |regulation of MAPK cascade| |positive regulation of cell differentiation| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |regulation of protein phosphorylation| |regulation of phosphorylation| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|1.7| |[[:results:exp156|UNC2400 2μM R03 exp156]]|1.7| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|1.72| |[[:results:exp432|YM155 0.001μM R08 exp432]]|1.72| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|2.24| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18691 * **Expression level (log2 read counts)**: 0.61 {{:chemogenomics:nalm6 dist.png?nolink |}}